ThreeD Capital Invests in Bioscience Innovator Lophos Holdings
Company Announcements

ThreeD Capital Invests in Bioscience Innovator Lophos Holdings

ThreeD Capital (TSE:IDK) has released an update.

ThreeD Capital Inc., a Canadian venture capital firm, has announced a strategic investment in Lophos Holdings Inc., acquiring common shares and warrants as part of a Securities Purchase Agreement. This move is set to bolster Lophos Holdings’ endeavors in the bioscience and wellness sectors, particularly their work with natural medicines. The deal, which is still subject to regulatory approval, marks a significant partnership aimed at driving innovative solutions in bioscience.

For further insights into TSE:IDK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Reports Latest Unaudited NAV
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Strengthens Investor Relations with PHK
TipRanks Canadian Auto-Generated NewsdeskThreeD Capital Reports Unaudited NAV of $0.86
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App